Figure 2.
The structures of inhibitors that target the NLRP3 inflammasome pathway for the treatment of depression.
The structures were obtained from https://pubchem.ncbi.nlm.nih.gov/ (Kim et al., 2023). (A) BAY 117082; (B) beta-hydroxybutyrate; (C) A438079; (D) MCC950; (E) Cli-095; (F) CY-09; (G) Brilliant Blue G; (H) VX765.